![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
DW Kufe, D Munroe, D Herrick, E Egan and D Spriggs
1-beta-D-Arabinofuranosylcytosine (ara-C) incorporates into DNA, and the extent of this incorporation correlates significantly with inhibition of DNA synthesis. The incorporated ara-C residue provides a poor primer terminus for further chain elongation. There is a highly significant relationship between formation of (ara-C) DNA and loss of clonogenic survival. The present studies confirm that incorporation of ara-C into DNA, and not the competitive inhibition of DNA polymerase, is responsible for inducing lethal cellular events. The results also demonstrate that the incorporated ara-C residue is not excised from the DNA strand. Furthermore, the presistence of ara-C residues in DNA inhibits recovery of DNA synthesis following exposure to drug. The relative DNA chain-terminating effect of ara-C provides several mechanisms of action that explain internucleotide and chain terminus positioning of ara-C residues, reinitiation of previously replicated DNA segments, and DNA strand or chromosomal breaks. The precise mechanism of action is dependent upon dose scheduling of this drug.
This article has been cited by other articles:
|
|
 |
|
  B. Ewald, D. Sampath, and W. Plunkett ATM and the Mre11-Rad50-Nbs1 Complex Respond to Nucleoside Analogue-Induced Stalled Replication Forks and Contribute to Drug Resistance Cancer Res., October 1, 2008; 68(19): 7947 - 7955. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wang, X. Liu, A. Matsuda, and W. Plunkett Repair of 2'-C-Cyano-2'-Deoxy-1-{beta}-D-arabino-Pentofuranosylcytosine-Induced DNA Single-Strand Breaks by Transcription-Coupled Nucleotide Excision Repair Cancer Res., May 15, 2008; 68(10): 3881 - 3889. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Lamba, K. Crews, S. Pounds, E. G. Schuetz, J. Gresham, V. Gandhi, W. Plunkett, J. Rubnitz, and R. Ribeiro Pharmacogenetics of Deoxycytidine Kinase: Identification and Characterization of Novel Genetic Variants J. Pharmacol. Exp. Ther., December 1, 2007; 323(3): 935 - 945. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhou, G. Achanta, H. Pelicano, V. Gandhi, W. Plunkett, and P. Huang Action of (E)-2'-Deoxy-2'-(fluoromethylene)cytidine on DNA Metabolism: Incorporation, Excision, and Cellular Response Mol. Pharmacol., January 1, 2002; 61(1): 222 - 229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ito, P. Pandey, M. B. Sporn, R. Datta, S. Kharbanda, and D. Kufe The Novel Triterpenoid CDDO Induces Apoptosis and Differentiation of Human Osteosarcoma Cells by a Caspase-8 Dependent Mechanism Mol. Pharmacol., April 16, 2001; 59(5): 1094 - 1099. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. Yoshida, R. Weichselbaum, S. Kharbanda, and D. Kufe Role for Lyn Tyrosine Kinase as a Regulator of Stress-Activated Protein Kinase Activity in Response to DNA Damage Mol. Cell. Biol., August 1, 2000; 20(15): 5370 - 5380. [Abstract] [Full Text]
|
|
|
|
 |
|
 Y. Ito, P. Pandey, A. Place, M. B. Sporn, G. W. Gribble, T. Honda, S. Kharbanda, and D. Kufe The Novel Triterpenoid 2-Cyano-3,12-dioxoolean-1,9-dien-28-oic Acid Induces Apoptosis of Human Myeloid Leukemia Cells by a Caspase-8-dependent Mechanism Cell Growth Differ., May 1, 2000; 11(5): 261 - 267. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. Roig and J. A. Traugh p21-activated Protein Kinase gamma -PAK Is Activated by Ionizing Radiation and Other DNA-damaging Agents. SIMILARITIES AND DIFFERENCES TO alpha -PAK J. Biol. Chem., October 29, 1999; 274(44): 31119 - 31122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Cline and N. Osheroff Cytosine Arabinoside Lesions Are Position-specific Topoisomerase II Poisons and Stimulate DNA Cleavage Mediated by the Human Type II Enzymes J. Biol. Chem., October 15, 1999; 274(42): 29740 - 29743. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Maruo, I. Oishi, K. Sada, M. Nomi, T. Kurosaki, Y. Minami, and H. Yamamura Protein tyrosine kinase Lyn mediates apoptosis induced by topoisomerase II inhibitors in DT40 cells Int. Immunol., September 1, 1999; 11(9): 1371 - 1380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z.-M. Yuan, Y. Huang, M.-M. Fan, C. Sawyers, S. Kharbanda, and D. Kufe Genotoxic Drugs Induce Interaction of the c-Abl Tyrosine Kinase and the Tumor Suppressor Protein p53 J. Biol. Chem., October 25, 1996; 271(43): 26457 - 26460. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Pandey, J. Raingeaud, M. Kaneki, R. Weichselbaum, R. J. Davis, D. Kufe, and S. Kharbanda Activation of p38 Mitogen-activated Protein Kinase by c-Abl-dependent and -independent Mechanisms J. Biol. Chem., September 27, 1996; 271(39): 23775 - 23779. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Harrington and F. W. Perrino The Effects of Cytosine Arabinoside on RNA-primed DNA Synthesis by DNA Polymerase alpha-Primase J. Biol. Chem., November 3, 1995; 270(44): 26664 - 26669. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ito, P. Pandey, P. Sathyanarayana, P. Ling, A. Rana, R. Weichselbaum, T.-H. Tan, D. Kufe, and S. Kharbanda Interaction of Hematopoietic Progenitor Kinase 1 and c-Abl Tyrosine Kinase in Response to Genotoxic Stress J. Biol. Chem., May 18, 2001; 276(21): 18130 - 18138. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
